SHE — Shedir Pharma Srl Unipersonale Share News
0.000.00%
- €55.45m
- €52.75m
- €59.39m
Brief: Shedir Pharma H1 Net Profit Stable At EUR 1.2 Mln
Brief: Shedir Pharma FY Net Profit Down At EUR 2.8 Mln
Brief: Shedir Pharma Gets Italian Patents For Banzinact And Visiopressin
Brief: Shedir Pharma Says Preventive Seizure Issued By Prosecutor At Court In Torre Annunziata Has Been Lifted
Brief: Shedir Pharma Obtains Italian Patent For Naxx
Brief: Shedir Pharma Gets Two Italian Patents For Constipation Treatments
Brief: Shedir Pharma Gets Two New Italian Patents
Brief: Shedir Pharma Announces Dymalife Pharmaceutical Acquired 3 Medicinal Products
Brief: Shedir Pharma H1 Net Profit Down At EUR 1.2 Mln
Brief: Shedir Pharma Obtains Italian Patent For Caverfill
Refile: BRIEF-Shedir Pharma Gets Italian Patent For Zexin
Brief: Shedir Pharma: European Patent Office Grants Patent For Wellflu
Brief: Shedir Pharma H1 Prelim. Revenue Up About 10% YoY